<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC7765853/table_6" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 6</label>
  <p>Anti-inflammatory activity of 
   <i>Origanum vulgare</i> L. essential oil (OEO). 
  </p>
 </caption>
 <thead>
  <tr>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-0-.">Details: Source, Phytochemical Composition; Dose, Formulation</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-1-.">Mechanism of Action</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-2-.">Reference</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">
    <i>Origanum vulgare subsp. hirtum</i> EO was provided 
    <br/>by Exentiae s.r.l. (Catania, Italy) 
    <br/>Phytochemical constituents were not mentioned 
    <br/>Nanostructured lipid carriers (NLC) loaded with OEO were obtained by phase inversion temperature and high-pressure homogenization, using two different emulsifiers systems (Tween80/Glyceryl oleate or Kolliphor RH40/Labrafil). 
    <br/>Tested concentrations of NLC loaded with OEO were: 0.001, 0.002, 0.003% 
    <i>v/v</i>
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">
    <b>decreases (↓)NO</b>
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B66-ijms-21-09653" ref-type="bibr">66</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">OEO was provided by Meritech Bioengineering Co. Ltd. (Guangzhou, China). 
    <br/>According to GS-MS analysis, OEO contained the following major constituents: 
    <br/>carvacrol (79.92%), 
    <br/>thymol (1.90%), 
    <br/>
    <i>γ</i>-terpinene (4.54%) 
    <br/>OEO concentrations used in the experiment ranged from 2.5 to 10 μg/mL. 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">↓IL-1β, IL-6, TNF-α, ↓ ROS, inhibitory activity of NADPH oxidase</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B67-ijms-21-09653" ref-type="bibr">67</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">
    <i>Origanum vulgare</i> L. was harvested from Chaing Mai, Thailand. 
    <br/>HPLC assay attested the presence of carvacrol (retention time = 3.381 min) as a major component of the OEO 
    <br/>Transdermal microemulsion (ME) from OEO was tested 
    <br/>IC 
    <sub>50</sub> = 6.8 μg/mL (↓ IL-6) and IC 
    <sub>50</sub> = 5.4 ± 2.3 (↓TNF-α) 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">↓IL-6, TNF-α</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B68-ijms-21-09653" ref-type="bibr">68</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 types of 
    <i>Origanum vulgare</i> L. were harvested from Supra- Mediterranean and Meso- Mediterranean bioclimatic zones of Spain. 
    <br/>OEO samples were analysed by GC-MS and the main constituents were: 
    <br/>
    <b>
     <i>β</i>
    </b>-Caryophyllene (0.5–4.9%), 
    <br/>thymol (0.2–5.8%), 
    <br/>
    <b>
     <i>p</i>
    </b>-cymene (3.8–8.2%), 
    <br/>
    <b>
     <i>γ</i>
    </b>-terpinene (2.1–10.7%), 
    <br/>carvacrol (58.7–77.4%) 
    <br/>IC 
    <sub>50</sub> = 251.5 µL EO/L 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">inhibitory activity of lipoxygenase (LOX)</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[ 
    <a rid="B69-ijms-21-09653" ref-type="bibr">69</a>] 
   </td>
  </tr>
 </tbody>
</table>
